About Single Dose Radiotherapy Services
The Intraoperative Radiation Therapy (IORT) instrument uses a linear accelerator in a similar manner as conventional radiotherapy for single-dose applications. This procedure is carried out in the operation room using a secure and compact instrument that works in a linear and accelerated fashion, releasing only electron energy while having less staff safety than conventional linear accelerators. In men with intermediate-risk prostate cancer, single-dose radiotherapy proved to be as healthy as hypofractionated stereotactic body radiotherapy. A single dose of targeted radiotherapy given during surgery is almost as effective as traditional radiotherapy, which involves several hospital stays following surgery for most women with early breast cancer. In organ-confined prostate cancer, ultra-high single-dose radiotherapy may be a viable alternative to curative severe hypofractionated stereotactic body radiotherapy.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 7.3% |
The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Single Dose Radiotherapy Services market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Varian Medical Systems (United States), Accuray Incorporated (United States), Elekta AB (Sweden), Ion Beam Applications (Belgium), Carl Zeiss AG (Germany), IsoRay Medical (United States), Hitachi (Japan), Provision Healthcare (United States), Mevion Medical Systems (United States) and Panacea Medical Technologies (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Accuray Incorporated (United States), ViewRay (United States) and Optivus Proton Therapy, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Single Dose Radiotherapy Services market by Type (External Beam Radiotherapy, Internal Beam Radiotherapy/Brachytherapy (Seeds, Applicators, Afterloaders) and Systemic Radiotherapy), Application (Hospitals and Specialty Clinics) and Region.
On the basis of geography, the market of Single Dose Radiotherapy Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Category, the sub-segment i.e. Image-guided Radiotherapy (IGRT) will boost the Single Dose Radiotherapy Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Indication, the sub-segment i.e. Breast Cancer will boost the Single Dose Radiotherapy Services market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Demand for Image-Guided Radiotherapy and Rising Implementation of Pencil-Beam Scanning
Market Growth Drivers:
Technical Progress in Radiology, Prevalence of Breast Cancer Cases Across the Globe and Growing Healthcare Infrastructure Due to Pandemic
Challenges:
Adverse Effects of Radiation Exposure
Restraints:
Lack of Trained Professionals and Costly Equipment
Opportunities:
Low Penetration Across Emerging Regions Particularly Asia and Increasing Enrollments for Medical Degrees
Market Leaders and their expansionary development strategies
In January 2024, Siemens Healthineers joined forces with the ZEISS Group to co-develop and market AI-powered radiotherapy planning solutions. This collaboration brings together Siemens’ proficiency in medical imaging and radiation therapy with ZEISS’s expertise in AI and visualization. The goal is to tailor treatment plans to individual patient needs, ultimately enhancing clinical outcomes.
In November 2023, Varian Medical Systems introduced the Halcyon 3.0 treatment planning system. Noteworthy features of the new system include AI-powered automation tools and streamlined workflows, with a promise of expedited treatment planning processes and heightened quality of patient care.
United States FDA 3-A Safety Standards; These are a Comprehensive list of Standards that Regulate Manufacturing and Implementation of Radiological Shield. Use of Harmful Chemicals such as Lead is Banned under USDA 3-A. and European Commission Radiation Protection 102 'Medical exposure directive' (97/43/Euratom); Provides Safe Use Norms for Of These Medical Imaging Modalities and Limits the Dosage Requirements in Accordance to Patient.
Key Target Audience
Single Dose Radiotherapy Manufactures, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.